OC vs OSK

The deterministic health profile is severely compromised, highlighted by a weak Piotroski F-Score of 2/9 and a bearish technical trend of 0/100. While analysts maintain a 'Buy' rating with a target of $138.19, the hard data reveals a sharp fundamental reversal characterized by negative profit margins (-5.17%) and crashing growth metrics. Revenue is declining rapidly (-16.8% YoY, -24.58% Q/Q) and EPS has plummeted by 65.8% YoY. The disconnect between analyst optimism and the deteriorating financial health suggests a significant risk of further price correction.

OSK presents a dichotomy between a fortress balance sheet and deteriorating growth metrics. With a Piotroski F-Score of 4/9, the company is stable but lacks strong operational momentum, while the current price of $156.30 significantly exceeds both the Graham Number ($127.75) and the growth-based intrinsic value ($70.14). Negative earnings growth (-10.10%) and a high PEG ratio (6.30) suggest the stock is currently overvalued relative to its fundamental growth. However, exceptionally low debt and a favorable forward P/E provide a significant safety floor.